Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 3, Number 1, February 2003

Review article

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
pp. 1-19(19)
Authors: Yusuf, R.Z.; Duan, Z.; Lamendola, D.E.; Penson, R.T.; Seiden, M.V.

Favourites:
ADD

Mechanisms Controlling Sensitivity to Platinum Complexes: Role of p53 and DNA Mismatch Repair
pp. 21-29(9)
Authors: Manic, S.; Gatti, L.; Carenini, N.; Fumagalli, G.; Zunino, F.; Perego, P.

Favourites:
ADD

Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase
pp. 31-40(10)
Author: Danilkovitch-Miagkova, A.

Favourites:
ADD

Molecular Targets of the Oncogenic Transcription Factor Jun
pp. 41-55(15)
Authors: Hartl, M.; Bader, A.G.; Bister, K.

Favourites:
ADD

The Prodigiosins: A New Family of Anticancer Drugs
pp. 57-65(9)
Authors: Montaner, B.; Prez-Toms, R.

Favourites:
ADD
Favourites:
ADD

Addenda

Author Index To Volume 2
pp. 83-83(1)
Author: Bentham, S.

Favourites:
ADD

subject Index To Volume 2
pp. 85-87(3)
Author: Bentham, S.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more